NanoVation Therapeutics™
United States
Member Since:Jan 31, 2024
Ownership:N/A
Number of Offices:N/A
Total Employees:11-50
Established In:2020
NanoVation Therapeutics™ (NTx) develops customized nucleic acid and lipid nanoparticle technologies to empower its partners’ genetic medicines. By enabling the safe and efficacious delivery of nucleic acids to a variety of tissues, NTx’s unique toolbox can rapidly advance therapeutic concepts into clinical reality. NTx is delivering tomorrow's genetic medicines, TODAY™.
No record available!
No record available!
No record available!
No record available!
No record available!
No record available!